MAY 2020
ISSUE
Please consider making a donation to your Society. Your donations will help us to improve the lives of people throughout the world through Patient Blood Management.
SABM 2020 Newsletter Publication
Editor: Kevin T. Wright
Associate Editor: Majed Refaai, MD
Contributors for This Issue
Christine Cahill, RN, MS
Ann Marie Gordon, PA-C, MLS (ASCP)
Beverly Khaek-On, BSN, RN
Mary Ann O'Brien, RN, MSN, CCRN, CNE
Sherri Ozawa, RN
Seth Perelman, MD, FASA
Majed Refaai, MD
Cassandra Upchurch, RN
Sarah Walbolt, BSN, RN
Kevin T. Wright
Marketing
Tim Bower, CAE
SABM Officers and
Directors
© 2020 Society for the Advancement of Patient Blood Management
19 Mantua Road Mt. Royal, NJ 08061 USA Phone: (928) 551-6400 Fax: (877) 944-2272 EMAIL: [email protected] |
News & Events
Transfusion-Free Medicine & Surgery: Efficacy, Ethics and Economics
Rhode Island Hospital, Providence, RI, USA
SABM members are well aware that continuing education is essential to the success of PBM initiatives. This is to report on my recent Surgical Grand Rounds presentation at Rhode Island Hospital, Providence, RI.
Rhode Island Hospital, a founding partner of Lifespan health system is a private, 719-bed, not-for-profit acute care hospital. We are the principal teaching hospital of The Warren Alpert Medical School of Brown University, the only Level 1 trauma center in the region and, our pediatric division Hasbro Children’s Hospital, is the premier pediatric facility for southeastern New England. Rhode Island Hospital is the first and only hospital in New England to offer PBM for all patients, including transfusion‑free medical or surgical procedures for patients who decline any use of allogenic blood products during their admission.
The educational goal of this presentation was to provide a review of PBM options and techniques, highlight the importance of ethics in patient care, and the role of anemia options such as iron and erythropoietin. PBM lays emphasis on patient rights and ethics in medicine, which includes autonomy or the right of self-determination is in many ways at the forefront. Patients should always be informed of the available options to blood products when advised of the need for a medical or surgical procedure. Efficacy of PBM was outlined by means of the Therapeutic Pharmacy guidelines that were developed and made available to all Lifespan clinicians. These guidelines provide indications, restrictions, and a patient evaluation synopsis. A treatment summary of actual cases is also included in the guidelines highlighting the effectiveness of erythropoiesis-stimulating agents, iron supplementation and so forth. The economic benefits of PBM at our hospital was calculated early on to result in a 23% decline in overall blood usage.
Stephanie Lueckel, MD, Medical Director of Transfusion-Free Medicine & Surgery, provided valuable insights from the surgeon’s perspective including the successful use of PBM strategies. She stressed the importance of the surgeon’s approach to a procedure, that is to say the need to show a willingness to incorporate and utilize PBM techniques. Joseph Sweeney, MD, Medical Director, Coagulation and Transfusion Medicine, stressed the importance of a restrictive transfusion policy regarding blood product usage. He has advocated this for many years both in lectures and when advising physicians. Visiting speaker Wayne Henderson, Associate Director, Hospital Information Services for Jehovah’s Witnesses, explained the role of the Hospital Liaison Committee Network. He noted that there are some 1,700 committees worldwide that can provide peer-reviewed papers and information, also facilitate physician-to-physician consultations by means of skilled physicians who are respectful of Jehovah’s Witness beliefs.
In general, PBM advocates multimodality and multidisciplinary approaches to patient care. The significant advantage at Rhode Island Hospital is the capability to identify patients prior to surgery and then successfully coordinate their care from pre‑admission status to discharge and follow‑up. Since our official open house in June 2006, thousands of patients have selected Rhode Island Hospital because we offer transfusion-free medicine & surgery. There has been the added benefit of growth in market share and associated cost savings in blood product expenditures.
Contributor: Kevin T. Wright
Pictured left to right: Joseph D. Sweeney MD, FACP, FRCPath, Medical Director, Coagulation and Transfusion Medicine, Lifespan Academic Medical Center, Professor of Pathology and Laboratory Medicine, Alpert Medical School of Brown University, Providence, RI; Stephanie Lueckel, MD, ScM, FACS, Section Chief of Trauma, Division of Trauma and Surgical Critical Care, Medical Director, Transfusion-Free Medicine & Surgery, Rhode Island Hospital; Kevin T. Wright, Program Administrator, Transfusion-Free Medicine & Surgery, Rhode Island Hospital; Wayne M. Henderson, Jr., Associate Director, Hospital Information Services for Jehovah’s Witnesses, Wallkill, NY.
Bloodless Surgery Presentation at WACS 2020, Abuja, Nigeria
The West African College of Surgeons (WACS) held its annual conference at the International Conference Centre in Abuja, Nigeria, February 17-20, 2020. SABM member Nathaniel Usoro, MD, a general surgeon who is a Fellow of WACS, was invited to speak on the topic of Bloodless Obstetrical Surgery. The simplicity, safety, effectiveness and superior outcomes of bloodless surgery techniques (which are also cheaper and ideal for developing countries) were highlighted and contrasted with the hazards and adverse outcomes of blood transfusion.
This is not the first time Bloodless Surgery has been featured at WACS. Dr. Usoro has previously facilitated WACS symposia on this topic, including a 2010 conference also in Nigeria, at which time fellow SABM members Shannon Farmer and Axel Hoffman lectured on the topic of Patient Blood Management. However, this is the first time the audience seemed to be “flowing completely” with the subject as Dr. Usoro observed. This is also the first time the Bloodless Medicine & Surgery Society (BMSS) – of which Dr. Usoro is currently President – featured a display at the WACS conference. Many delegates expressed support for bloodless surgery and requested information on both the BMSS as well as SABM.
Pictured: Nathaniel Usoro, MD
2020 Call for Board of Directors Nominations
Nominations Deadline: Monday, June 8, 2020
The Nominating Committee is pleased to invite SABM members to submit nominations for candidates to serve on the Board of Directors. Nominations are being accepted now through Monday, June 1. This year, there are four (4) At-Large Director positions.
All ACTIVE* members may submit the name of a member in good standing or their own name. Submissions should be sent to Tim Bower at [email protected] by midnight, Monday, June 8, 2020. Potential nominees will be contacted to confirm their willingness and availability to serve. Further information on the nomination and election process can be found in the SABM Bylaws.
Board of Director Responsibilities
- The Board of Directors shall have full responsibility for the management, direction and control of the business, policies and affairs of the Corporation, subject only to the limitations set forth in the Articles of Incorporation, the Bylaws, or by applicable law. (See Bylaw 6.1)
- Members of the Board of Directors are required to observe and promote the highest standards of ethical conduct in the performance of their responsibilities to SABM. Board of Directors must sign and comply with the Code of Conduct and the Conflicts of Interest and Confidentiality Disclosure forms.
- Members of the Board of Directors will serve a 2-year term beginning in September at the Annual Meeting of the membership. (See Bylaw 6.3)
- Members of the Board of Directors shall participate in six (6) Board meetings each calendar year. These meetings consist of:
- Five (5) teleconference meetings usually in January, March, May, July, November
- One (1) face-to-face meeting at the Annual Meeting in September.
- Members of the Board serve as a Board Representative on one of SABM’s committees, as assigned by the President, in order to facilitate communication between the Board and the committees. Regular contact between the Chair of the Committee or Activity and Board Representative is required. Board Representatives keep the Board informed of progress on charges and activities, and work with the chairs to ensure that charges are completed in a timely manner.
Should you have any questions, contact the SABM Office at (928) 551-6400 or via email at [email protected].
* Per SABM Bylaws Article IV, ACTIVE members include Allied Health, Executive, Hospital Affiliate, Physician, and Technologist member types.
SABM 2020 Annual Meeting - Call for Abstracts
The Society for the Advancement of Blood Management (SABM) invites members and non-members to submit abstracts related to the field of Patient Blood Management. Accepted abstracts will be published in the SABM Supplement of Anesthesia & Analgesia and will be presented at the SABM 2020 Annual Meeting in Las Vegas, Nevada.
Abstract Submission Deadline: June 8, 2020
The top three abstracts will be selected for oral presentation and given an award.
Abstract categories
- Clinical Research
A. Anemia Detection/Treatment/Management
B. Coagulation Issues/Management
C. Blood Conservation Modalities/Devices/Techniques
- Quality and Safety
A. Patient Blood Management Outcomes
B. Morbidity and Mortality
C. Patient Experience/Patient Centered Care
- Medical Economics and Regulatory/Advocacy
- Case Series/Report - Only those that have a significant novel approach will be considered.
- Basic Science
- Additional
Submit your abstract by June 8, 2020. Please note that you will be required to create a user account. Once the account is set up, you will then click on the link that reads "Submit Your Abstract Now".
* Per SABM Bylaws Article IV, ACTIVE members include Allied Health, Executive, Hospital Affiliate, Physician, and Technologist member types.
SABM Research Grant Call for Applications
Supported by a grant from HemoSonics, LLC
SABM Research Grant - Call for Applications
$25,000 one-year Patient Blood Management grant
Call for Applicants February 11, 2020
Application deadline June 1, 2020
Award notification July 1, 2020
Funding to begin October 1, 2020
The SABM Research Grant is intended to advance the field of patient blood management by an supporting an investigator who intends to study methods of promoting blood conservation. This one-year grant provides starter funding to further scientific inquiry and clinical knowledge in the field of patient blood management. Preference will be given to junior faculty who will be advised by an experienced mentor. It is anticipated that the funded study will generate results that can be used as pilot data or preliminary findings to support future grant applications focused on methods to improve patient blood management and to promote blood conservation. It is expected that all applicants will be members of SABM, or will become members of SABM for at least one year.
Information regarding the application process are available at the SABM website (www.SABM.org). Applications will be due by June 1, 2020. The awardee will be informed by July 1, 2020 and it is mandatory that the grant recipient be able to attend the SABM annual meeting September 9-12, 2020 at Caesar’s Palace, Las Vegas, NV to be formally recognized. Funding will begin October 1, 2020. The $25,000 does not include any extra funding to cover indirect institutional costs. Scholarly activity generated by this grant will be presented to the SABM members at the SABM annual meeting in 2021, and is expected to be published in peer-reviewed journals. A progress report submitted to the SABM research committee is expected 12 months after the funding is issued.
|
Consider submitting your future manuscripts in PBM for peer review and publication in this new section. The success of this endeavor will depend on the provision of material to make it lively and attractive to our colleagues and other professionals in the field.
Members Invited to Submit Papers CLICK HERE
|
